199 related articles for article (PubMed ID: 33395068)
1. Sodium dichloroacetate attenuates the growth of B16-F10 melanoma in vitro and in vivo: an opportunity for drug repurposing.
do Nascimento RS; Nagamine MK; De Toledo GF; Chaible LM; Tedardi MV; Del-Grande MP; da Fonseca IIM; Dagli MLZ
Anticancer Drugs; 2021 Feb; 32(2):111-116. PubMed ID: 33395068
[TBL] [Abstract][Full Text] [Related]
2. Ilexgenin A induces B16-F10 melanoma cell G1/S arrest in vitro and reduces tumor growth in vivo.
Yang H; Liu C; Zhang YQ; Ge LT; Chen J; Jia XQ; Gu RX; Sun Y; Sun WD
Int Immunopharmacol; 2015 Feb; 24(2):423-431. PubMed ID: 25596038
[TBL] [Abstract][Full Text] [Related]
3. DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft.
Zheng MF; Shen SY; Huang WD
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1031-41. PubMed ID: 24043136
[TBL] [Abstract][Full Text] [Related]
4. The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.
Seguin F; Carvalho MA; Bastos DC; Agostini M; Zecchin KG; Alvarez-Flores MP; Chudzinski-Tavassi AM; Coletta RD; Graner E
Br J Cancer; 2012 Sep; 107(6):977-87. PubMed ID: 22892389
[TBL] [Abstract][Full Text] [Related]
5. Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase.
Ferreira AK; Meneguelo R; Marques FL; Radin A; Filho OM; Neto SC; Chierice GO; Maria DA
Biomed Pharmacother; 2012 Oct; 66(7):541-8. PubMed ID: 22902646
[TBL] [Abstract][Full Text] [Related]
6. Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by induction of apoptosis in melanoma B16-F10 cells.
Youn MJ; Kim JK; Park SY; Kim Y; Park C; Kim ES; Park KI; So HS; Park R
J Ethnopharmacol; 2009 Jan; 121(2):221-8. PubMed ID: 19041933
[TBL] [Abstract][Full Text] [Related]
7. Amiodarone's major metabolite, desethylamiodarone inhibits proliferation of B16-F10 melanoma cells and limits lung metastasis formation in an in vivo experimental model.
Bognar Z; Cseh AM; Fekete K; Antus C; Bognar R; Tapodi A; Ramadan FHJ; Sumegi B; Gallyas F
PLoS One; 2020; 15(9):e0239088. PubMed ID: 32977329
[TBL] [Abstract][Full Text] [Related]
8. Effect of dichloroacetate on Lewis lung carcinoma growth and metastasis.
Kolesnik DL; Pyaskovskaya ON; Boychuk IV; Dasyukevich OI; Melnikov OR; Tarasov AS; Solyanik GI
Exp Oncol; 2015 Jun; 37(2):126-9. PubMed ID: 26112940
[TBL] [Abstract][Full Text] [Related]
9. A potent tumoricidal co-drug 'Bet-CA'--an ester derivative of betulinic acid and dichloroacetate selectively and synergistically kills cancer cells.
Saha S; Ghosh M; Dutta SK
Sci Rep; 2015 Jan; 5():7762. PubMed ID: 25585916
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.
Pópulo H; Caldas R; Lopes JM; Pardal J; Máximo V; Soares P
Expert Opin Ther Targets; 2015 Jun; 19(6):733-45. PubMed ID: 25976231
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell.
Yao Z; Che XC; Lu R; Zheng MN; Zhu ZF; Li JP; Jian X; Shi LX; Liu JY; Gao WY
Mol Med; 2007; 13(1-2):14-21. PubMed ID: 17515953
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
13. Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.
Bastos DC; Paupert J; Maillard C; Seguin F; Carvalho MA; Agostini M; Coletta RD; Noël A; Graner E
Lab Invest; 2017 Feb; 97(2):194-206. PubMed ID: 27918556
[TBL] [Abstract][Full Text] [Related]
14. Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro.
Kolesnik DL; Pyaskovskaya ON; Gorbach O; Solyanik GI
Exp Oncol; 2020 Mar; 42(1):35-39. PubMed ID: 32231186
[TBL] [Abstract][Full Text] [Related]
15. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6.
Kolesnik DL; Pyaskovskaya ON; Yurchenko OV; Solyanik GI
Exp Oncol; 2019 Jun; 41(2):123-129. PubMed ID: 31262158
[TBL] [Abstract][Full Text] [Related]
16. Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study.
Senff-Ribeiro A; Echevarria A; Silva EF; Veiga SS; Oliveira MB
Anticancer Drugs; 2004 Mar; 15(3):269-75. PubMed ID: 15014361
[TBL] [Abstract][Full Text] [Related]
17. Dangguibuxue decoction abolishes abnormal accumulation of erythroid progenitor cells induced by melanoma.
Li C; Zhu F; Xu C; Xiao P; Wen J; Zhang X; Wu B
J Ethnopharmacol; 2019 Oct; 242():112035. PubMed ID: 31226383
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of sodium dichloroacetate against glioma C6 depends on administration schedule and dosage.
Fedorchuk AG; Pyaskovskaya ON; Gorbik GV; Prokhorova IV; Kolesnik DL; Solyanik GI
Exp Oncol; 2016 Jun; 38(2):80-3. PubMed ID: 27356574
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
20. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
